In the present study we examined mRNA and protein levels for the muscle/adipose tissue glucose transporter (GLUT-4) in various tissues of spontaneously obese mice (C57BL/KsJ, db/db) and their lean littermates (db/+). Obese (db/db) mice were studied at 5 wk of age, when they were rapidly gaining weight and were severely insulin resistant, evidenced by hyperglycemia (plasma glucose 683±60 vs. 169±4 mg/dl in db/+, P < 0.05) and hyperinsulinemia (plasma insulin 14.9±0.53 vs.
Introduction
Non-insulin dependent diabetes mellitus (NIDDM)' is a heterogeneous disease that is probably polygenic in nature. One of the major pathophysiological disorders of NIDDM is peripheral insulin resistance. This appears to be due at least in part to a defect in muscle tissue, the major site of whole body insulindependent glucose disposal (1, 2) . One possible candidate for this defect is the glucose transporter, because glucose transport appears to be the rate-limiting step for glucose utilization in muscle (3) .
Facilitated diffusion glucose transport is catalyzed by a family of tissue-specific proteins (4, 5) . These include: the HepG2-type transporter (GLUT-1) which is ubiquitously expressed in mammalian tissues but is present at highest levels in brain, placenta, and erythrocytes (6, 7) ; the liver-type transporter (GLUT-2) which is present in splanchnic tissues, kidney, and pancreatic islets (8, 9) ; and the muscle/adipose tissue transporter (GLUT-4) which is expressed in tissues that exhibit insulin-dependent glucose transport, i.e., muscle and fat (10) (11) (12) (13) (14) . Therefore, defective whole body glucose homeostasis due to defects in specific tissues, as is observed in NIDDM, could hypothetically arise from a lesion in any one of these glucose transporters.
Spontaneously obese mice have been a useful model for genetic analysis ofinsulin resistance and diabetes susceptibility (15) . The diabetes (db) mutation on chromosome 4 in the homozygous conditions produces hyperphagia, progressive obesity, insulin resistance, and hyperglycemia, a syndrome similar to NIDDM in man. The initial adaptation to the insulin resistance is one of islet beta cell hyperplasia resulting in marked hyperinsulinemia, but ultimately islets develop beta cell necrosis, insulinopenia, severe hyperglycemia, and weight loss (16) . The response to the obesity-induced insulin resistance in mice differs according to the inbred strain, and genetic analysis has provided evidence that multiple genes are involved (17, 18) .
Previous studies have shown that insulin-stimulated glucose transport in muscle is impaired in the db/db mouse (19) (20) (21) (22) . Because glucose transport appears to be the rate-limiting step for glucose utilization in skeletal muscle (23) , these data implicate this initial step as a potential locus for the defect resulting in insulin resistance. Such a defect could encompass the glucose transporter per se, or part ofthe signal transduction pathway whereby insulin augments glucose transport. The insulin resistance of streptozotocin diabetic and fasted rats has recently been extensively characterized in adipose cells (24) (25) (26) (27) Tissue and blood sampling. The mice were killed in the fed state using pentobarbitol sodium (100 mg/kg, i.p.). Blood was collected from the orbital sinus and then pancreas, quadriceps, and gastrocnemius muscle, diaphragm, epididymal fat pads, and heart were removed, weighed, frozen in liquid nitrogen, and stored at -70'C until analysis.
cDNA probes, synthetic mRNA standards, and antibodies. The cDNA probes used for study were as follows: (a) a mouse proinsulin I cDNA fragment isolated from a mouse pancreatic cDNA library (28), (b) the muscle/adipose tissue glucose transporter (GLUT-4) cDNA, isolated from rat adipocyte and heart cDNA libraries as described (10) , was used at a serum concentration such that the final concentration of protein was 10 ,ug/ml. A polyclonal antibody (R820), specific for a carboxy-terminal synthetic peptide of insulin-regulatable glucose transporter (10) , was used by diluting serum to a final protein concentration of 5 ,ug/ml.
Quantitation ofmRNAs and DNA. Total tissue RNA was extracted using a guanidine thiocyanate method (29) . All samples had 28S/1 8S RNA ratios over 2.0 on ethidium bromide staining after electrophoresis on agarose gels, and also showed discrete actin mRNA bands on Northern blot analysis.
Initial studies to validate the specificity of each cRNA probe were performed using Northern analysis. Once the appropriate stringency for hybridization ofeach clone was established, quantitation of mRNA levels between the mice was performed using dot blot analysis. Aliquots of total tissue RNA (1-10 ytg) and dilutions of synthetic mRNA (0.5-1,000 pg) and of cDNA ( 1-1,000 pg) as standards were dissolved in 15% formaldehyde/lOX standard saline citrate (SSC) and blotted onto Nytran (Schleicher & Schuell, Inc., Keene, NH) membranes. Membranes were hybridized to the corresponding probes for 16-18 h (proinsulin and GLUT-4 at 60°C, actin at 55°C) in 50% formamide, 5X SSPE, and then washed (proinsulin and GLUT-4 at 60°C, actin at 52°C) in 0.1 X SSC, 0.1% SDS, according to the instructions recommended by the vendor. Blots were exposed to Kodak XAR5 film at -70°C using intensifying screens (Cronex Lightening Plus; E. I. Dupont de Nemours Co., Wilmington, DE). The amount of mRNA present in each sample, determined in duplicate, was measured by densitometric analysis, comparing the intensity of the sample dot with standard dots. Autoradiographs were developed for various periods oftime so that the intensity of the unknown samples was within the linear range of the standards.
DNA was measured in crude tissue homogenates by a spectrofluorometric assay (30) .
Immunoblotting. In preparation for SDS-PAGE, tissue samples were diluted 1:10 (wt/vd) with ice-cold PBS (pH 7. (24) (25) (26) (27) .
To determine whether the marked differences in fed plasma glucose and insulin between the two groups of mice could be accounted for by different levels of GLUT-4 gene expression, mRNA levels were quantitated in diaphragm, heart, skeletal muscle, and adipose tissue. Initial studies with GLUT-4 and the HepG2/erythrocyte (GLUT-1) cDNA probes indicated that the ratio of GLUT-4 to GLUT-I mRNA was 80:1 in rat skeletal muscle and 60:1 in mouse heart. Once these studies defined the major GT mRNA in these tissues, quantitation of GLUT-4 mRNA levels was accomplished by dot blot analysis using synthetic mRNA standards (Table II) .
Total tissue RNA (Table II) and DNA (Table III) did not differ between db/db and db/+ mice, except in adipose tissue where both RNA (P < 0.05) and DNA (P < 0.05) were reduced in db/db mice. The GLUT-4 mRNA concentration (Table II) was reduced in quadriceps (67.5±8.5%, P < 0.02) of db/db mice, but not in heart (95.7+6 1%, NS), in diaphragm The mRNA levels were consistent when expressed relative to tissue DNA as an index of cell number. The GLUT-4/actin mRNA ratio was similarly reduced in quadriceps of db/db mice. Muscle/adipose tissue glucose transporter protein in insulin-sensitive tissues. The level of GLUT-4 in various tissues from obese (db/db) and lean (db/+) mice was measured by immunoblotting using a polyclonal antisera (R820) ( Table  III) . Quantitation was performed in two separate analyses and showed that there was no significant difference between control and db/db mice. DNA content differed between db/db and db/+ mice only in adipose tissue, but GLUT-4 protein/Ag DNA did not differ (30.7±5.4 cpm/jg DNA for db/+ vs.
48.4±8.6 cpm/,ug DNA for db/db mice, mean±SEM, P = 0.1 1). Identical data were obtained using the monoclonal antibody IF8 (data not shown). An illustrative immunoblot is shown in Fig. 1 .
Discussion
Human obesity is a complex disorder that is characterized by peripheral insulin resistance. Although a cause-effect relationship between these factors has not been established, the basis for peripheral insulin resistance is being extensively studied. Previous studies have shown that skeletal muscle is the primary tissue responsible for whole body insulin resistance in human obesity (31) . The regulation of glucose transport by insulin has become a focal point of studies attempting to understand insulin resistance because it appears to be the ratelimiting step for glucose utilization in these tissues (23) . Insulin stimulates glucose transport in muscle and adipose tissue by 10-30-fold (32) (33) (34) . While the signal transduction pathway has not been established, it seems evident that a major mechanism that may account for this insulin-dependent increase in glucose transport is translocation of glucose transporters from an intracellular domain to the cell surface (32). The GLUT-4 level at the plasma membrane is increased by at least 10-fold after exposure of rat adipose tissue to insulin (10) . Thus, a decrease in tissue GLUT-4 levels could conceivably result in a decreased response to insulin. In this study we have shown that in young obese mice, which have previously been shown to exhibit marked insulin resistance and impaired glucose transport in muscle, the GLUT-4 protein levels in five insulin-responsive tissues do not differ from those in their insulin-sensitive lean littermates.
Because there, are obvious marked differences in body weight and degree of adiposity in obese and lean mice, we have attempted to assess the levels of glucose transporter mRNA and protein on a per cell basis by normalizing to tissue DNA content. For all tissue other than adipose tissue, neither protein, RNA, or DNA content (Tables II and III ) differed between the two groups of mice. Thus for these four insulin-regulated tissues, the GLUT-4 protein and mRNA concentrations appear to be a reasonable reflection of the levels on a per cell basis. In contrast, in adipose tissue of obese mice, protein appeared to decrease 15% (NS, A discrepancy between GLUT-4 mRNA and protein levels was noted in quadriceps in the present study (Tables II and  III) . However, we have previously documented a discrepancy in GLUT-4 mRNA and protein levels among insulin-sensitive tissues of control rats (10) . In those studies, marked changes in the GLUT-4 protein per microgram total protein were noted among different muscle and adipose tissues, whereas no such differences were found in mRNA levels per microgram total Red Quadriceps Insulin resistance appears to be one of the initial defects in NIDDM (35) . Insulin resistance is most commonly defined by defective utilization of carbohydrates primarily by skeletal muscle and to a lesser extent adipose tissue (1, (31) (32) (33) . Many animal models of obesity have proven useful for the study of NIDDM in humans because they exhibit insulin resistance in these tissues. Stauffacher and Renold ( 19) noted impaired glucose utilization in adipose tissue and diaphragm of 8-wk-old ob/ob mice relative to that in lean mice. Cuendet et al. (20) noted decreased uptake of 2-deoxyglucose by soleus muscle, with and without insulin, and that the maximal insulin response was less in young ob/ob mice compared with that in lean mice. Chan et al. (21, 22) evaluated glucose metabolism and insulin sensitivity in 5-6-wk-old db/db mice by the perfused hindquarter method. Both basal and insulin-stimulated glucose uptake, ['4C]glucose oxidation, and lactate production were diminished in obese (db/db) mice, while the half-maximal effective insulin dose did not differ. These data have led to the conclusion that the marked decrease in glucose utilization in young db/db mouse skeletal muscle is probably due to a major defect in glucose transport. The current studies now show that this glucose transport defect in muscle is not accompanied by significant changes in the total level of insulin-regulatable glucose transporter protein. Thus, at least in this model, changes in total muscle glucose transporter can be eliminated as a cause of insulin resistance. It is noteworthy that in denervated skeletal muscle, which is also markedly insulin resistant with respect to glucose transport (36) , there is no decrease in GLUT-4 protein concentration in skeletal muscle (James, D., and J. Lawrence, unpublished data). Thus, in these seemingly different models, both of which result in insulin resistance, the total GLUT-4 protein is unaffected.
That the insulin resistance of obesity in young db/db mice cannot be accounted for by changes in GLUT-4 protein of muscle is especially interesting in light of recent studies in adipose cells of diabetic and fasted rats (24) (25) (26) (27) . Under these conditions insulin resistance was associated with a 50-60% decrease in GLUT-4 mRNA and a 50-87% decrease in GLUT-4 protein in adipose cells, while the translocation of glucose transporter with insulin treatment remained intact (27) . These results in adipose cells (24) (25) (26) (27) and skeletal muscle (27) of diabetic rats strongly suggested that the impaired insulin-stimulated glucose transport in this condition is due to a depletion of muscle/adipose tissue glucose transporter protein.
In contrast, the insulin resistance of obese mice does not appear to be related to pretranslational changes in muscle/adipose tissue glucose transporter expression, but rather to changes in signal transduction, translocation, or functional activity of the protein.
